Answers from the Lab

William Morice II, M.D., Ph. D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice discuss how traveling and gathering impacts respiratory virus spread, and how testing and lab stewardship wi...

(00:32)  Could you provide a little bit of background about yourself? (01:43)  Could you give a brief overview of the new melanoma assay? (04:53)  Is the assay able to provide diagnostic, prognostic and classification information, and potential therapeutic implications? (05:12)  Could you talk a little more about the MSI assessment in this panel?  (05:59)  Which patients should have this testing?...

(00:32)  Could you provide us a little background about yourself? (01:44)  Could you give us a brief overview of the new Mayo complete colorectal panel assay? (03:44)  Can you go a little bit into more detail on guidelines and therapeutic implications concerning these specific genes?   (06:09)  Which patients should have this testing? (08:00)  Are there any last pieces you'd like to add about the...

(00:32)  Could you provide us some background about yourself? (01:34)  Could you give us a brief overview of the new Mayo complete lung cancer assay? (03:31)  Can you talk a little bit more about the specific genes and why they're important for patient care? (04:53)  When would a clinician pathologist order a focused NGS panel, such as this new Mayo complete lung cancer panel, over a larger cancer...

(00:31)  Could you tell us a little bit about yourself and your background? (01:15)  Can you give us a little understanding of this disease state and why a tailored evaluation for pediatric patients is important? (02:47)  What makes it more challenging to diagnose a pediatric autoimmune neurological disorder? (03:32)  Is the tailored evaluation necessary because different antibodies are evaluated?...

On this week’s episode of the "Answers From the Lab" podcast, Bobbi Pritt, M.D., is joined by Matthew Binnicker, Ph. D., director of the Clinical Virology Laboratory at Mayo Clinic. Dr. Pritt and Dr. Binnicker discuss why it could be a rough influenza season, testing options for patients with respiratory infections, and how to protect yourself from illness.

(0:32)  Will you tell us a bit about yourself and your background?   (01:35)  Can you help us understand what type of tests you perform in your laboratory and how the results can be used to support patient care?   (02:18)  When is it important to consider urine drug testing, and what is our recommended approach?   (03:59)  Could you help us understand more about forensic toxicology and when to con...

William Morice II, M.D., Ph. D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice discuss the stabilization of monkeypox and COVID-19, the shift from pandemic to endemic status, the increase...

William Morice II, M.D., Ph. D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice cover current trends for monkeypox and COVID-19, their thoughts as autumn begins, getting back to infection...

William Morice II, M.D., Ph. D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice discuss the Saving Access to Laboratory Services Act (SALSA), how it is designed to mitigate harmful effects...

(00:32)  Could you provide a little bit of background about yourself, please? (01:01)  Please give us a brief overview of the new PIK3CA assay.   (02:09)   Why do we offer two different tests, and when should each be ordered? (03:58)  Which patients should have this testing? (04:39)  Is this testing used for patients being considered for second-line treatment after first-line hormone receptor trea...

William Morice II, M.D., Ph. D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, they discuss Dr. Morice’s new role as CEO and president of Mayo Clinic Laboratories (MCL), his patient-centered vision for the future...

(00:31)  Could each of you please provide a little bit of background about yourself? (01:18)  Let's start with a general definition of primary ciliary dyskinesia (PCD) for our audience. (02:21)   PCD is rare. Dr. Maleszewski, can you talk about the implications of that? (02:39)  What is the current state of PCD diagnosis in the U.S. and globally, and what are the implications for patient care? (03...

(00:32)   Would you mind sharing a bit about yourself and your background? (01:44)  Would it be fair to say you're an expert on this topic? (01:57)  Could you help us understand the role of laboratory testing in supporting recovery from alcohol use disorders, and how to approach testing for those patients? (04:50)  Could you help us understand our new direct alcohol biomarker test and its benefits...

William Morice II, M.D., Ph. D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice discuss current challenges in lab medicine and what it means to be a laboratory leader, including innovation...

(00:31)  Can you both tell us a little bit about yourselves and your backgrounds? Dr. Moyer, do you want to start? (01:51)  Your background, Dr. Janetto? (02:47)   Please provide an overview of major depressive disorder and the test that Mayo Clinic Laboratories has available for therapeutic drug monitoring as well as pharmacogenomics. (07:05)  Which patients should have this testing, and when sho...

(00:31)  Would each of you share a little about yourselves and your backgrounds? (01:17)  Could you please provide us with an overview of what types of genetic testing for inherited kidney diseases are available Mayo Clinic Labs? (02:35)   Can you expand on why genetic testing for kidney disease is important? (04:30)  Who could benefit from genetic testing for inherited kidney diseases? (05:55)  W...

William Morice II, M.D., Ph. D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice discuss the latest monkeypox developments, potential scenarios for monkeypox moving forward, and where the VALID Act...

(00:32)   Would you mind telling our listeners a little about yourself and your background?   (01:16)  This evaluation is about CIDP — chronic inflammatory demyelinating polyneuropathy, correct?   (02:16)  Can you give us an overview of what the CIDP evaluation will consist of?   (04:38)  Our standalone test for neurofascin-155 won't change, but will be rolled into this new test along with contact...

William Morice II, M.D., Ph. D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice discuss how monkeypox can be transmitted, the possibilities of a future Emergency Use Authorization (EUA), and acces...

(00:31)   Could you tell us a bit about yourself and your background? (01:11)  Could you describe these new tests and when it would be appropriate to use each of them in the clinic? (03:16)  Could you provide a little background on why MCL is making changes to the PLA2R test? (04:34)  Could you describe the change to KDIGO guidelines and when it may be appropriate to skip the biopsy? How will thes...

William Morice II, M.D., Ph. D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice discuss new developments in monkeypox testing, updates on the federal response, and lessons learned from managing ot...

(00:32)  Could you please provide a bit about yourself and your background? (01:39)  Could you please give a basic overview of the NPM1Q test and why we are so pleased to offer it? (06:56)   Which patients should have this test and when should it be performed? Is it when they are initially diagnosed? (09:44)  How would translocation 8;21 and inversion 16 tests be incorporated into testing for pati...

John Osborn, operations administrator in the Department of Laboratory Medicine and Pathology at Mayo Clinic, joins the "Answers From the Lab" podcast for a discussion with host Bobbi Pritt, M.D. about monkeypox testing. In this episode, John and Dr. Pritt discuss how Mayo Clinic swiftly operationalized monkeypox testing and the challenges involved with supporting the new assay, including staffing....

(01:51)  Can you give a brief overview of the assay you developed and how it works? (06:28)  The serotonin release assay is utilized within five to 14 days of heparin exposure. Is there a subsequent time when this test would be utilized? (10:28)   How does this assay improve upon previous approaches? (12:58)  Is there greater specificity and sensitivity with the use of nonradioactive materials? (1...